RZV Vaccine (Shingrix ®)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which RZV Vaccine (Shingrix ®) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT07534007

Comprehensive Characterization of Immune Response Induced by Adjuvanted Glycoprotein E (gE)-Based Recombinant VAccine Zo…

Varicella-zoster virus (VZV) is one of the eight herpesviruses that infect humans by manifesting as varicella. After primary infection VZV remains latent for li…

Italy150 participantsStarted 2026-02-24

All recent trials (5 shown)

Active — Not RecruitingPhase 4

NCT05879419

Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases

Introduction: Patients with autoimmune rheumatic diseases (ARDs), rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), psoriatic arthritis (PAs), ank…

Brazil2,005 participantsStarted 2023-05-23

Treatment: Recombinant Herpes Zoster Vaccine (RZV), MTX Discontinuation

Active — Not RecruitingPhase 4

NCT05575830

Immune Response of Shingrix Vaccine in People Living With HIV (> 50 y.o.) Compared to Age-matched Controls

The purpose of this study is to evaluate the efficacy and safety of the adjuvanted recombinant Zoster vaccine (RZV, or Shingrix®) in older people (\> 50 years)…

France, Switzerland225 participantsStarted 2022-12-14

Treatment: Recombinant Zoster Vaccine

RZV Vaccine (Shingrix ®)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Comprehensive Characterization of Immune Response Induced by Adjuvanted Glycoprotein E (gE)-Based Recombinant VAccine Zo…

All recent trials (5 shown)

Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases

Immune Response of Shingrix Vaccine in People Living With HIV (> 50 y.o.) Compared to Age-matched Controls

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Comprehensive Characterization of Immune Response Induced by Adjuvanted Glycoprotein E (gE)-Based Recombinant VAccine Zo…

All recent trials (5 shown)

Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases

Immune Response of Shingrix Vaccine in People Living With HIV (> 50 y.o.) Compared to Age-matched Controls

Simultaneous RZV and aIIV4 Vaccination

Immunogenicity of the Recombinant Zoster Vaccine in Multiple Sclerosis Patients